Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 207.00K | 234.00K | 241.00K | 208.00K | 222.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 207.00K | 234.00K | 241.00K | 208.00K | 222.00K |
| Cost of Revenue | 815.00K | 771.00K | 684.00K | 820.00K | 804.00K |
| Gross Profit | -608.00K | -537.00K | -443.00K | -612.00K | -582.00K |
| SG&A Expenses | 8.80M | 9.02M | 9.15M | 9.42M | 8.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.64M | 23.17M | 22.32M | 20.64M | 19.92M |
| Operating Income | -23.43M | -22.93M | -22.08M | -20.43M | -19.70M |
| Income Before Tax | -23.40M | -23.11M | -23.76M | -21.79M | -21.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.40 | -23.11 | -23.76 | -21.79 | -21.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.40M | -23.11M | -23.76M | -21.79M | -21.27M |
| EBIT | -23.43M | -22.93M | -22.08M | -20.43M | -19.70M |
| EBITDA | -23.13M | -22.62M | -21.78M | -20.16M | -19.46M |
| EPS Basic | -7.79 | -10.34 | -12.43 | -13.69 | -14.09 |
| Normalized Basic EPS | -4.01 | -5.32 | -6.39 | -6.47 | -6.62 |
| EPS Diluted | -7.79 | -10.34 | -12.43 | -13.69 | -14.09 |
| Normalized Diluted EPS | -4.01 | -5.32 | -6.39 | -6.47 | -6.62 |
| Average Basic Shares Outstanding | 22.33M | 14.06M | 9.30M | 8.39M | 8.07M |
| Average Diluted Shares Outstanding | 22.33M | 14.06M | 9.30M | 8.39M | 8.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | -2.63% | -7.66% | -11.17% | -20.06% |